[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 67, "title": "CEO, CFO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Skare Ph.D.", "title": "Vice President & Global Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.34, "open": 2.34, "dayLow": 2.11, "dayHigh": 2.355, "regularMarketPreviousClose": 2.34, "regularMarketOpen": 2.34, "regularMarketDayLow": 2.11, "regularMarketDayHigh": 2.355, "payoutRatio": 0.0, "beta": 1.646, "forwardPE": -0.23355265, "volume": 3879098, "regularMarketVolume": 3879098, "averageVolume": 7708109, "averageVolume10days": 4060060, "averageDailyVolume10Day": 4060060, "bid": 2.04, "ask": 2.23, "bidSize": 46, "askSize": 46, "marketCap": 317802880, "fiftyTwoWeekLow": 0.53, "fiftyTwoWeekHigh": 3.3, "allTimeHigh": 5627700.0, "allTimeLow": 0.53, "fiftyDayAverage": 1.5544, "twoHundredDayAverage": 0.98165, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 312362848, "profitMargins": 0.0, "floatShares": 102195342, "sharesOutstanding": 149003210, "sharesShort": 7594147, "sharesShortPriorMonth": 1037875, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0509, "heldPercentInsiders": 0.00014999999, "heldPercentInstitutions": 0.40897, "shortRatio": 0.45, "shortPercentOfFloat": 0.051, "impliedSharesOutstanding": 149203210, "bookValue": 0.352, "priceToBook": 6.0511365, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -11226000, "trailingEps": -2.07, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": -27.271, "52WeekChange": -0.024999976, "SandP52WeekChange": 0.1028198, "quoteType": "EQUITY", "currentPrice": 2.13, "targetHighPrice": 21.0, "targetLowPrice": 6.0, "targetMeanPrice": 11.66667, "targetMedianPrice": 8.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 5227000, "totalCashPerShare": 0.035, "ebitda": -11454000, "totalDebt": 211000, "quickRatio": 1.508, "currentRatio": 1.963, "debtToEquity": 6.569, "returnOnAssets": -0.87811995, "returnOnEquity": -2.28635, "freeCashflow": -6624500, "operatingCashflow": -10084000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Palisade Bio, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -8.97435, "regularMarketPrice": 2.13, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-11-21", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1763772982, "regularMarketTime": 1763758801, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Palisade Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": 0.009380036, "postMarketPrice": 2.1302, "postMarketChange": 0.00019979477, "regularMarketChange": -0.21, "regularMarketDayRange": "2.11 - 2.355", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 7708109, "fiftyTwoWeekLowChange": 1.6000001, "fiftyTwoWeekLowChangePercent": 3.0188684, "fiftyTwoWeekRange": "0.53 - 3.3", "fiftyTwoWeekHighChange": -1.1699998, "fiftyTwoWeekHighChangePercent": -0.3545454, "fiftyTwoWeekChangePercent": -2.4999976, "dividendDate": 1563408000, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.07, "epsForward": -9.12, "epsCurrentYear": -0.52333, "priceEpsCurrentYear": -4.07009, "fiftyDayAverageChange": 0.57560015, "fiftyDayAverageChangePercent": 0.37030375, "twoHundredDayAverageChange": 1.1483501, "twoHundredDayAverageChangePercent": 1.1698163, "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]